epilepsy Flashcards
what is the aim of epilepsy control
prevent the occurrence of seizures by maintaining an effective dose of one or more antiepileptic drugs
what should you consider when choosing an antiepileptic drug
- first the presenting epilepsy syndrome
- If the syndrome is not clear, the seizure type should determine the choice of treatment
- note you should also take into account patients other medication, co-morbidity, age, and sex*
what determines the dosage frequency of antiepileptic drugs
The plasma half life.
- frequency of doses should be kept as low as possible to encourage adherence to meds
which antiepileptics can be given once daily due to their long half life
(acronym: LPPP)
- Lamotrigine
- perampanel
- phenobarbital
- phenytoin
how do you switch a patient from one antiepileptic to another
- if first line monotherapy has failed, check the diagnosis again and then consider starting a second drug (monotherapy)
- slowly withdraw the first drug only when the new regimen with the second drug has been established
what are the disadvantages of combination therapy with antiepileptics
increased risk of:
- adverse reactions
- drug interactions
note monotherapy with antiepileptics should be prescribed whenever possible
why should patients/carers be advised to report any mood changes, distressing thoughts/feelings when taking antiepileptics
because all antiepileptics are associated with an increased risk of suicidal thoughts and behaviours
note this can be seen as early as 1 week into treatment
Should a patient taking antiepileptics stop treatment if they are experiencing suicidal thoughts/behaviours
No, do not stop or switch antiepileptic treatment. Seek advice from a healthcare professional if concerned
why are antiepileptic drugs categorised into 3 risk-based categories
to help healthcare professionals decide whether it is necessary to supply a specific manufacturers version of antiepileptic drug
what are the 3 risk-based categories of antiepileptics
name examples of antiepileptic drugs in each category
- CATEGORY 1: ensure patient is maintained on a specific manufacturer’s product.
e. g Carbamazepine, phenobarbital, phenytoin, primidone - CATEGORY 2: need to supply a specific manufacturers product based on clinical judgement + consultation with the patient and/or carer taking into account factors such as seizure frequency, treatment history, and potential implications to the patient of having a breakthrough seizure.
E.g clobazam, clonazepam, eslicarbazepine acetate, lamotrigine, oxcarbazepine, perampanel, rufinamide, topiramate, valproate, zonisamide
- CATEGORY 3: it is usually unnecessary to ensure that patients are maintained on a specific manufacturer’s product as therapeutic equivalence can be assumed.
e. g Brivaracetam, ethosuximide, gabapentin, lacosamide, levetiracetam, pregabalin, tiagabine, vigabatrin
name the antiepileptic drugs (category 1) that you need to make sure a patient stays on a specific manufacturer’s brand
- Carbamazepine
- phenobarbital
- phenytoin
- primidone
what are the symptoms of Antiepileptic hypersensitivity syndrome
name some antiepileptics are associated with this
fever, rash, and lymphadenopathy (enlarged lymph node) are most commonly seen. other signs could be liver dysfunction, renal/pulmonary abnormalities, multi-organ failure.
antiepileptics associated with this: carbamazepine, lamotrigine, oxcarbazepine, phenobarbital, phenytoin, primidone, and zonisamide
note symptoms can start between 1-8 weeks of starting treatment
what should happen if a patient shows symptoms of antiepileptic hypersensitivity syndrome
the drug should be withdrawn immediately, the patient must not be re-exposed, and expert advice should be sought
what normally causes interactions between antiepileptic drugs
hepatic enzyme induction or inhibition
note interactions between antiepileptics are varibale + unpredictable
how do you withdraw a patient taking an antiepileptic
- should be withdrawn under specialist supervision
- Avoid abrupt withdrawal (particularly of barbiturates and benzodiazepines)
- In patients receiving several antiepileptic drugs, only one drug should be withdrawn at a time
why must you avoid abrupt withdrawal especially when a patient is taking barbiturates (e.g phenobarbital) and benzodiazepines (e.g clonazepam, clobazam)
because abrupt withdrawal in these can cause severe rebound seizures
note withdrawal of barbiturates can take months
what are the rules around epilepsy + Driver and Vehicle Licensing Agency (DVLA).
- If a driver has a seizure (of any type) they must stop driving immediately and inform DVLA
- DVLA recommends not to drive during medication changes or withdrawal. if a seizure occurs during this, driving license revoked for 1 year
- after first unprovoked epileptic seizure or a single isolated seizure do not drive for 6 months. Then assessed by specialist as fit to drive
- those with established epilepsy can drive as long as not danger to public + compliant with treatment. Must be seizure-free for at least one year or have no history of unprovoked seizures
- if a seizure occurs whilst asleep, stop driving for 1 year from last seizure date. unless pattern established that seizures only occur during sleep over 1 year
what is the risk of taking antiepileptic drugs whilst pregnant
when is this risk the highest
increased of teratogenicity
highest risk:
- during first trimester
- if patient is taking 2 or more antiepileptic drugs